Vivimed Labs
 | |
| Company type | Public Limited Company (NSE: VIVIMEDLAB, BSE: 532660, ISIN: INE526G01013) |
|---|---|
| Industry | Chemicals, Manufacturing |
| Founded | 1988 |
| Headquarters | Hyderabad, India |
Key people | Dr. V. Manohar Rao(Chairman) Santosh Varalwar (CEO), Dr. Richard Smith (COO), Sandeep Varalwar(Executive Director) |
| Products | Active Ingredients, APIs, Hair-Dyes, Photochromics |
| Revenue | INR 9,524.66 million (2019)[1] |
 INR 4344.69 million (2019)[1] | |
| INR 2040.11 million (2019)[1] | |
Number of employees | 3000+ (2019)[2][failed verification] |
| Website | www.vivimedlabs.com |
Vivimed Labs Limited (NSE|VIVIMEDLAB, BSE532660) is an India-based global supplier of specialty chemicals and pharmaceuticals. Headquartered in Hyderabad, India, Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.[3][4]
Vivimed Labs operates in 60+ countries[citation needed] and SBUs based in America (Vivimed Labs USA Inc) and Europe (Vivimed Labs Europe) along with a marketing office in China.
The major areas of concentration are cosmetics, pharmaceuticals, Nutraceuticals, Photochromics, Natural Actives, colors and dyes. Since 2005, Vivimed has acquired James Robinson, UK and Har-Met International Inc.. The company currently has five manufacturing plants located in India along with R&D labs in the UK and India[citation needed].
The company's current slogan is "The Beauty of Chemistry".
History
Vivimed was originally incorporated as M/s Emgi Pharmaceuticals & Chemicals Private Limited in 1988.[5] The company was founded by Dr. V. Manohar Rao, who is today the Chairman of Vivimed Labs Limited. In 1997, the name changed to Vivimed Labs Limited. Vivimed was mainly into health care until its foray into the Home and Personal Care industry came with the advent of Triclosan. Rapid advances in the H&PC sector led to the company being listed with the BSE and the NSE in 2005. In 2007, VVS Pharma, a sister company which operated in the pharmaceutical and health-care sector merged with Vivimed Labs. The Specialty Chemicals Division was headed by Santosh Varalwar and the Health Care division was headed by Sandeep Varalwar.
In 2008, Vivimed Labs acquired James Robinson,[6] a 170-year-old manufacturer of hair dyes, fluorescents, solvent ink dye markers and photochromics. James Robinson continued to operate independently until its assimilation into the Vivimed Group in 2010. James Robinson was renamed Vivimed Labs Europe in April 2010. Dr. Richard Smith, the MD of James Robinson before and during its acquisition was appointed as the COO of Vivimed Labs Limited. Its manufacturing base was shifted from Germany to Hyderabad, India. The Kilo Lab for Photochromics and hair dye R&D is still located in Huddersfield, UK. The James Robinson brand names of Jarocol for its hair dyes and Reversacol for photochromic dyes have been retained.
In 2009, Vivimed acquired Har-Met, a specialty chemicals distributor chain based in Pennsylvania. In 2010, Har-Met was incorporated as Vivimed Labs USA Inc. Vivimed Labs USA Inc operates as a separate SBU in America, the biggest market in the home and personal care industry, and its neighboring countries.
Specialty chemicals
In 1997, Hyderabad-based Vivimed Labs started manufacturing Triclosan, a product with anti-microbial properties and able to be incorporated in formulations. Vivimed entered this market supplying of Triclosan. In 2002, Vivimed diversified its product range and ventured into the other areas of the home and personal care sector.
Its current product range includes Sunscreens, Anti-wrinkle, Skin lightening, Preservative, Anti-dandruff, Hair Growth, Hair conditioners, Anti-microbial and Oral care.
Vivimed Health Care
Vivimed Health Care is the pharmaceutical vertical of Vivimed Labs. Vivimed Health Care manufactures finished formulations and active pharmaceutical ingredients(APIs). The manufacturing units are located in Haridwar, Kashipur and Hyderabad and their R&D is located in Hyderabad. The major markets are the countries of the erstwhile USSR and Africa.
Drugs manufactured by Vivimed Health Care cater to the areas of diabetes, nutritional supplements, tuberculosis, oncology, hygiene and infectious diseases.
Time Line
- 1988: Founded as Emgi Pharmaceuticals
- 1997: Commenced manufacturing of Triclosan. Name Changed to Vivimed Labs
- 1998: Diversification into other areas of Home and Personal Care industry
- 2002: Consolidation, capacity expansions product innovations
- 2005: Public Listing of Vivimed Labs
- 2007: VVS Pharma joins Vivimed Group
- 2008: Acquisition of James Robinson
- 2009: Acquisition of Har-Met
- 2010: James Robinson and Har-Met merged into the Vivimed group to become Vivimed Labs Europe and Vivimed Labs USA Inc respectively
- 2011: Acquisition of Octtantis Nobel, India-based marketing company with focus on nutraceuticals and pharmaceuticals
- 2011: Acquisition of Klar Sehen Pvt., India-based pharma company with specialities in ophthalmic products and delivery systems
- 2011: Acquisition of Uquifa, API manufacture company ex- Yule Catto with facilities in Spain and Mexico.
References
- ^ a b c http://www.moneycontrol.com/annual-report/vivimedlabs/directors-report/VL07
- ^ "Vivimedlabs.com". . Vivimed Labs . Retrieved 25 September 2010.
- ^ http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/vivimedlabs/VL07
- ^ "Vivimed Labs Ltd". The Economic Times. Retrieved 22 May 2018.
- ^ http://www.sebi.gov.in /dp/vivi.pdf
- ^ "Company Profile: James Robinson". Rsc.org. Retrieved 25 September 2010.